In vitro susceptibility to infection with SIVcpz and HIV-1 is lower in chimpanzee than in human peripheral blood mononuclear cells

Journal of Medical Virology

Volumn 67, Issue 3, 2002, Pages 301-311

  Ondoa, Pascale ^a   Davis, David ^a   Kestens, Luc ^a   Vereecken, Chris ^a   Ribas, Sergio Garcìa ^a   Fransen, Katrien ^a   Heeney, Jonathan ^b   Van Der Groen, Guido ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

Primate; Susceptibility to infection; Viral replication

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; FAS ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CHIMPANZEE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; MONONUCLEAR CELL; NONHUMAN; RETROVIRUS INFECTION; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

ANIMALS; CELLS, CULTURED; CHEMOKINES, CC; DISEASE SUSCEPTIBILITY; DNA, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; PAN TROGLODYTES; PROVIRUSES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SPECIES SPECIFICITY; VIRAL LOAD; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; PAN TROGLODYTES; PRIMATES;

EID: 0036273751     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10078     Document Type: Article

References (47)

1. Human immunodeficiency virus envelope glycoprotein/CD4 mediated fusion of nonprimate cells with human cells
2. Design and evaluation of an in-house HIV-1 (group M and O), SIVmnd and SIVcpz antigen capturing assay
3. Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins
4. High titers of cytopathic virus in plasma of patients with symptomatic HIV-1 primary infection
5. Identification of RANTES, MIP-1α and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells
6. Transient high level of viremia in patients with primary human immunodeficiency virus type 1 infection
7. Identification of a major co-receptor for primary isolates of HIV-1
8. Cloning and sequence of primate CD4 molecules: Diversity of the cellular receptor for the simian immunodeficiency virus/human immunodeficiency virus
9. Design and evaluation of newly highly sensitive and specific primers for polymerase chain reaction of HIV-1 infected primary lymphocytes
10. Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype
11. The resistance of HIV-infected chimpanzees to progression to AIDS correlates with the absence of T-cell dysfunction
12. Concentrations of soluble CD95 and CD8 antigens in the plasma and levels of CD8+CD95+, CD8+CD38+ and CD4+ CD95+ T cells are markers for HIV-1 infection and clinical status
13. Concentrations of circulating β-chemokines do not correlate with viral load in human immunodeficiency virus-infected individuals
14. Phenotypic and functional parameters of cellular immunity in a chimpanzee with a naturally acquired simian immunodeficiency virus infection
15. SIVcpz-ant causes a non-escalating immune activation and uses multiple co-receptors in chimpanzees
16. The relative resistance of HIV type 1-infected chimpanzees to AIDS correlates with the maintenance of follicular architecture and the absence of infiltration by CD8+ cytotoxic T lymphocytes
17. Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcriptase in T cells
18. The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection
19. Homozygous defect in HIV-1 co-receptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
20. Do β-chemokines have clinical relevance in HIV infection?
21. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein
22. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain
23. Quantitation of HIV-1RNA predicts outcome after seroconversion
24. Prognosis in HIV-1 infection predicted by the quantity of virus in the plasma
25. Apoptosis and apoptosis-associated perturbations of peripheral blood lymphocytes during HIV infection: Comparison between AIDS patients and asymptomatic long term non-progressors
26. Genotypic subtypes of HIV-1 in Cameroon
27. Study of the dynamics of neutralization escape mutants in a chimpanzee naturally infected with the simian immunodeficiency virus SIVcpz-ant
28. Longitudinal comparison of virus load parameters and CD8 T-cell suppressive capacity in two SIVcpz infected chimpanzees
29. Virologic and serologic characteristics of a natural chimpanzee lentivirus infection
30. Isolation and characterization of a new chimpanzee lentivirus (simian immunodeficiency virus cpz-ant) from a wild-captured chimpanzee
31. Isolation and partial characterization of an HIV-related virus occurring naturally in chimpanzees in Gabon
32. Reduction of HIV concentration during acute infection: Independence from a specific immune response
33. Human immunodeficiency virus genetic variation that can escape cytotoxic T-cell recognition
34. Comparison of early events during infection of human and chimpanzee peripheral blood mononuclear cells with HIV-1
35. Chimpanzee CXCR4 and CCR5 act as coreceptor for HIV type 1
36. A simple method of estimating fifty percents end points
37. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
38. A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1
39. The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes
40. HIV-1 replication is controlled at the level of T-cell activation and proviral integration
41. Identification of a novel nuclear pore-associated protein as a functional target of the HIV-1 Rev protein in yeast
42. A pathogenic threshold of virus load defined in immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques
43. Genomic-cloning and complete sequence analysis of a highly divergent African immunodeficiency virus isolate
44. Sequence analysis of a highly divergent HIV-1 related lentivirus isolated from a wild-captured chimpanzee
45. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA
46. HIV-1 production from infected peripheral blood T cells after HTLV-1 induced mitogenic stimulation
47. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure